CD55, also known as Decay-Accelerating Factor (DAF) is an inhibitor of the complement system, and is broadly expressed in malignant tumors. In cancer, CD55 has been implicated in tumorigenesis, neoangiogenesis, and metastasis. CD55 may decrease complement mediated tumor cell lysis, inhibit tumor apoptosis, and promote invasive cancer cell motility. These roles in cancer may involve binding to the seven-span transmembrane receptor CD97. In neuroblastoma cells, CD55 contributes to growth of colonies and to invasion of cells, but not to stemness. In neuroblastoma cells, CD55 is upregulated in a small population of cells that are HIF-2α positive. This CD55-positive subpopulation is highly invasive and has low adhesion to fibronectin and collagen. In addition, CD55 expression correlates with poor prognosis in neuroblastoma patients.
Cimmino F et al. (2016) Oncogenesis 5:e212.Mikesch JH et al.(2006) Cell Oncol. 28(5-6):223.
The products are are safely shipped at ambient temperature for both domestic and international shipments. Each product is guaranteed to match the specifications as indicated on the corresponding technical data sheet. Please store at -20C upon arrival for long term storage.
*All molecular weights (MW) are confirmed by comparison to Bio-Rad Rainbow Markers and to western blotmobilities of known proteins with similar MW.
This kit contains:
ECM Biosciences是一家著名的生物公司,开发新的生物技术的生命科学研究。公司工程与研究机构全球发展创新的工具,以提高研究和治疗相关的神经病理学,癌症,免疫功能障碍和心血管疾病。ECM Biosciences 的科学合作重点在分子组成部分,产生细胞运动的变化,细胞形状,促进细胞运动和细胞结构确定。细胞运动的重要作用在肿瘤细胞迁移,免疫细胞浸润,以及神经和血管修复。各种蛋白质在细胞外机质(ECM)周围细胞信号蛋白在细胞内的细胞骨架,以控制细胞运动 ECM Biosciences 生物利用创新肽和抗体为基础的办法,发展新的工具来检测和操作蛋白质功能的各个方面的细胞运动,如细胞黏附,细胞迁移和细胞信号。